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Acceptability of minitablets in children is important to those working in pharmaceutical 
development to ensure medicines meet the needs of patients. Previous work showed that tablets 
are superior to alternative oral formulations in children aged 1-4 years1. Klingmann et al provide 
evidence that multiple minitablets (up to 400) are accepted by children aged 2-5 years. The study is 
limited by ethical requirements to include only children who are (i) able to swallow and (ii) are 
compliant and willing to accept the study procedures both of which may introduce bias in study 
outcomes. Reluctance to use solid dosage forms is often attributed to risks associated with choking 
yet no deglutition issues were detected with minitablets in a total of 372 participants. Taste is not an 
issue for  placebo minitablets which may not be valid for a commercial product. Future work should 
focus on the acceptability of commercial minitablets with the associated hurdles associated with a 
real paediatric population and a real drug product.  
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